Orchid Pharma Limited (ORCHPHARMA) signs licensing agreement with Pharmasyntez to commercialize Exblifep® in Russia, targeting USD 178 million over 10 years.
Wockhardt Limited (WOCKPHARMA) receives CDSCO approval for Zaynich® antibiotic for treating complicated urinary tract infections.